Skip to content
Review

Advances towards biological hearing restoration by genetic reprogramming.

Aug 2026 · Current Opinion in Otolaryngology & Head and Neck Surgery · Vol 34, pp. 303-307 · 0 citations · 61 references
Medicine

TL;DR

To develop viable gene therapies, future research must identify the molecular mechanisms that maintain supporting cell identity in the mature cochlea, and target and suppress these gene networks in addition to activating hair cell gene networks.

Abstract

Purpose

OF REVIEW Advances in genetic reprogramming and groundbreaking first-in-human gene therapy trials have generated significant momentum for treating sensorineural hearing loss. This review evaluates the expanding potential of biological approaches for hearing restoration. RECENT

Findings

The mammalian organ of Corti possesses limited natural regenerative capacity. Recent studies are attempting to restore hearing by genetically reprogramming supporting cells into hair cells. While merely modulating cell signaling pathways in the inner ear is currently insufficient to regenerate hair cells, expressing hair cell-specific specific transcription factors can partially activate hair cell identity. However, current attempts at reprogramming are only partially successful, yielding only immature and nonfunctional "hair cell-like cells." SUMMARY To develop viable gene therapies, future research must identify the molecular mechanisms that maintain supporting cell identity in the mature cochlea. Targeting and suppressing these gene networks in addition to activating hair cell gene networks is essential to improve the complete transition of supporting cells into functional hair cells, paving the way for translating these regenerative strategies into effective clinical treatments.

View source

Similar papers

Review Open access Sep 2026

In Vivo Direct Reprogramming: Current Progress and Future Prospects from Mechanisms to Therapeutic Application

ABSTRACT Direct reprogramming, which converts somatic cells from one lineage to another without passing through a pluripotent state, represents a promising therapeutic strategy for regenerative medicine. Recent advancements in identifying reprogramming factors and understanding molecular barriers have enabled efficient...

R. Singh, Mauro Calvoli, Kyeong Kyu Kim · 0 citations
#gene editing Review Aug 2026

A translational framework for early-phase inner-ear gene therapy: clinical trial design, regulatory strategy, and ethical considerations.

The genetics of hearing loss is transitioning from a diagnostic modality to an interventional one, with emphasis on emerging gene-based therapies, clinical trial design, regulatory and ethical considerations, and practical implications for otolaryngologists as biologic treatment enters clinical practice.

Emma C. Dunn, Spencer H Short, Ravi N Samy · 0 citations
Open access Aug 2026

Transcriptional landscape of direct reprogramming toward the hematopoietic lineage

This experimental-computational framework offers a generalizable strategy for characterizing partially reprogrammed states and guiding optimization of reprogramming protocols.

Jillian Cwycyshyn, Cooper M. Stansbury, S. Golts et al. · 0 citations
Review Open access Jan 2026

The Role and Mechanism of Hair Follicle Neural Crest Stem Cells and Their Small Extracellular Vesicles in Repair of Peripheral Nerve Injury

Peripheral nerve injury (PNI) remains a vital clinical challenge due to the limited efficacy of current therapeutic strategies. Autologous nerve grafting, the gold standard for repairing PNI, remains limited by certain donor site morbidity, and alternative approaches include cell therapy, nerve conduits, gene therapy,...

Jia-Chen Zheng, Si-Ying Fei, Yang Xu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.